A p-value approach to assessing In-vitro nonprofile bioequivalence
碩士 === 國立成功大學 === 統計學系碩博士班 === 90 === In 1999, the U.S. Food and Drug Administration（FDA）issue a graft guidance on Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. For individual bioequivalence（IBE）, the FDA provided a method of determining an upper 95...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2002
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/69905591238992377387 |